NZ332555A - Gene expression in monocytes and macrophages associated with the CD68 gene - Google Patents
Gene expression in monocytes and macrophages associated with the CD68 geneInfo
- Publication number
- NZ332555A NZ332555A NZ332555A NZ33255597A NZ332555A NZ 332555 A NZ332555 A NZ 332555A NZ 332555 A NZ332555 A NZ 332555A NZ 33255597 A NZ33255597 A NZ 33255597A NZ 332555 A NZ332555 A NZ 332555A
- Authority
- NZ
- New Zealand
- Prior art keywords
- polynucleotide
- gene
- monocytes
- macrophages associated
- vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9609261.4A GB9609261D0 (en) | 1996-05-02 | 1996-05-02 | Gene expression in monocytes and microphages |
PCT/GB1997/001209 WO1997042337A1 (en) | 1996-05-02 | 1997-05-02 | Gene expression in monocytes and macrophages |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ332555A true NZ332555A (en) | 2000-03-27 |
Family
ID=10793127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ332555A NZ332555A (en) | 1996-05-02 | 1997-05-02 | Gene expression in monocytes and macrophages associated with the CD68 gene |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0914456B1 (xx) |
JP (1) | JP2001504683A (xx) |
AT (1) | ATE321143T1 (xx) |
AU (1) | AU732705B2 (xx) |
CA (1) | CA2253322A1 (xx) |
DE (1) | DE69735535T2 (xx) |
ES (1) | ES2260793T3 (xx) |
GB (1) | GB9609261D0 (xx) |
NZ (1) | NZ332555A (xx) |
WO (1) | WO1997042337A1 (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003504033A (ja) * | 1999-07-06 | 2003-02-04 | グラクソ グループ リミテッド | Dna構築物 |
JP2004522403A (ja) * | 1999-11-03 | 2004-07-29 | パウダージェクト ヴァクシンズ,インコーポレイテッド | 抗原発現を駆動する哺乳動物cd80/cd86遺伝子プロモーターを有する核酸ワクチン組成物 |
DE10001169A1 (de) * | 2000-01-13 | 2001-07-26 | Reske Kunz Angelika B | Regulatorische Sequenz zur spezifischen Expression in dentritischen Zellen und deren Anwendungen |
CN113621611B (zh) * | 2021-04-26 | 2024-04-19 | 北京美康基免生物科技有限公司 | 一种髓系特异性启动子及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9305759D0 (en) * | 1993-03-19 | 1993-05-05 | Medical Research Council And T | Hiv therapy method and agents |
GB9319772D0 (en) * | 1993-09-24 | 1993-11-10 | Therexsys Ltd | Therapeutic agent |
US6110666A (en) * | 1994-06-09 | 2000-08-29 | Medical Research Council | Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure |
-
1996
- 1996-05-02 GB GBGB9609261.4A patent/GB9609261D0/en active Pending
-
1997
- 1997-05-02 NZ NZ332555A patent/NZ332555A/xx unknown
- 1997-05-02 ES ES97920819T patent/ES2260793T3/es not_active Expired - Lifetime
- 1997-05-02 JP JP53964397A patent/JP2001504683A/ja not_active Ceased
- 1997-05-02 EP EP97920819A patent/EP0914456B1/en not_active Expired - Lifetime
- 1997-05-02 AT AT97920819T patent/ATE321143T1/de not_active IP Right Cessation
- 1997-05-02 DE DE69735535T patent/DE69735535T2/de not_active Expired - Fee Related
- 1997-05-02 CA CA002253322A patent/CA2253322A1/en not_active Abandoned
- 1997-05-02 AU AU27054/97A patent/AU732705B2/en not_active Ceased
- 1997-05-02 WO PCT/GB1997/001209 patent/WO1997042337A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69735535T2 (de) | 2006-09-07 |
EP0914456A1 (en) | 1999-05-12 |
EP0914456B1 (en) | 2006-03-22 |
WO1997042337A1 (en) | 1997-11-13 |
GB9609261D0 (en) | 1996-07-03 |
ES2260793T3 (es) | 2006-11-01 |
ATE321143T1 (de) | 2006-04-15 |
AU732705B2 (en) | 2001-04-26 |
AU2705497A (en) | 1997-11-26 |
CA2253322A1 (en) | 1997-11-13 |
JP2001504683A (ja) | 2001-04-10 |
DE69735535D1 (de) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0260148A3 (en) | Improved recombinant expression method, vector and transformed cells | |
MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
UA27706C2 (uk) | Спосіб одержання гетерологічного поліпептиду | |
ES8404409A1 (es) | Un metodo de expresion de un gen. | |
GB8610600D0 (en) | Transformation of trichoderma | |
ES8600783A1 (es) | Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano. | |
ES8302774A1 (es) | Un metodo para producir un vector de clonacion mejorado. | |
DE3463510D1 (en) | (21-leucine) human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and process for production thereof | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
ZA887773B (en) | Interleukin-7 | |
EP0176971A3 (en) | Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof | |
AU600253B2 (en) | Expression of eucaryotic proteins | |
WO1999021976A3 (en) | Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins | |
AU577810B2 (en) | Cloning the gene for rabbit tumor necrosis factor polypeptide | |
NZ332555A (en) | Gene expression in monocytes and macrophages associated with the CD68 gene | |
EP0776972A4 (en) | GENE ENCODING THE IgG-Fc-BINDING PROTEIN | |
NZ334146A (en) | Generating immortalised chicken cells to be used for propagating virus and producing recombinant proteins | |
AU7949991A (en) | Cloned n-methylhydantoinase | |
AU1720397A (en) | Recombinant expression of s-layer proteins | |
HU9403600D0 (en) | Method for producing protein c | |
DE3479816D1 (en) | A promotor and use thereof | |
HUP0003541A2 (hu) | Expressziós vektor polipeptidek javított hatékonyságú előállítására élesztőben | |
NZ503537A (en) | Clostridium toxin, and method for preparing immunogenic compositions | |
AU5309586A (en) | Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms | |
NZ298801A (en) | Thrombolytic agent from Staphlococcus aureus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |